|
Mission Statement
|
The mission of the Academy of Compounding Pharmacists is to promote, protect and provide quality compounding services; maintaining high quality and professional standards in pharmacies for the optimum health outcomes of California patients.
|
|
Upcoming
Events & CE
| |
Full Calendar of Events
CPh-PAC & IPA California present: Comedy Night Fundraiser
May 18, 2014
Buena Park, CA
Pharmacy-Based Immunization Training
May 31, 2014
Sacramento, CA
Delivering Medication Therapy Management Services
June 14, 2014
Sacramento, CA
EdNet Symposium
August 2, 2014
Los Angeles, CA
EdNet Symposium
August 16, 2014
San Francisco, CA
Compounders Day
September 27, 2014
Orange, CA
_____________________
Click Here for Detailed
Local Association Events
|
|
Sponsor
|
Sponsorship of this newsletter is available. Please contact Jamie Carota at (916) 779-4511 or [email protected].
CPhA members who belong to the ACP benefit with discounts from Analytical Research Laboratories. Click on the ARL logo to learn more.
|
|
ACP Successfully Halts Sterile Compounding Regulations
Last month, the Board of Pharmacy (BOP) announced that it is withdrawing its proposed regulations to modify California sterile compounding law. The ACP Board worked closely with CPhA Center for Advocacy staff to send a lengthy letter explaining our serious concerns with certain components of the proposal. As compounding pharmacists, we support vigorous standards to protect patients from unqualified or unsafe providers. However, the proposed regulations released by the BOP contained a number of problems that needed to be addressed. We support consistency with USP 797 standards and the BOP's proposed regulations made much progress to that goal. The ACP Board will continue to participate in stakeholder discussions with the BOP and others as new draft regulations are developed.
|
 |
PCAB and ACHC Discussions
Announcement
From the Pharmacy Compounding Accreditation Board...
We are aware of speculation in the industry about a potential consolidation of ACHC and PCAB accreditation activities. Although we cannot discuss specific details at this time, we do want you to know that ACHC and PCAB are in discussions and that we believe the outcome of these discussions will have a positive impact on the industry and the pharmacies we serve.
We are committed to maintaining the integrity and prominence of our program and will take the necessary steps to ensure that you continue to realize the value you expected when you partnered with PCAB.
These discussions should cause no disruption in the services PCAB provides to you or the schedules to which we have committed. Please continue to maintain any dialogue, timelines, and processes with PCAB. Compliance with standards, payments, and accreditation status will all be honored at the completion of these discussions. In short, stay the course and expect "business as usual."
|
|
|
Compounding Facilities Invited to Participate in 2014 USP Chapter <797> Compliance Study
Sterile compounding practices are invited to participate in the 2014 United States Pharmacopeia (USP) <797> Compliance Study. The study, the largest and most comprehensive study of USP compliance, will remain open until June 30, 2014. The 2014 USP <797> Compliance Study uses a sophisticated, web-based <797> Gap Analysis Tool developed by Kate Douglass, MS, RN, APN, C, CRNI, and Eric Kastango, MBA, FASHP and is available at no charge to all study participants. Participating facilities will also receive a highly detailed action plan that provides documentation for beginning or continuing compounding practice improvements. More information and a link to register for and begin the study are available at www.797study.com.
Results of the 2013 study showed that overall compliance with USP Chapter <797> was nearly unchanged from the 2012 rate at 77.2%. A full report on the 2013 survey results is available in the October 2013 issue of Pharmacy Purchasing & Products Magazine.
|
|
|
|
The latest Health Policy Brief from Health Affairs and the Robert Wood Johnson Foundation examines the Compounding Quality Act, a law signed by President Obama in November 2013, which seeks to fill the gaps in the Food and Drug Administration's (FDA's) inspection and enforcement oversight of compounding pharmacies. Read more...
|
|
|
